Etrinabdione oral solution clinical trials

A Phase IIa Open Label, Dose-Finding, Clinical Trial to Evaluate Safety, Tolerability and Preliminary Efficacy of Etrinabdione in Patients with Peripheral Arterial Disease (PAD). CLAUDIA Trial

This study, called CLAUDIA, is testing a new medicine called Etrinabdione for peripheral arterial disease (PAD). It's looking at how safe the medicine is and if it helps improve blood flow and symptoms like leg pain while walking. It's an early-stage study.